China's COVID-19 reopening measures-warriors and weapons.
作者信息
Huang Shujie, Gao Zhen, Wang Sichao
机构信息
Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong, Academy of Medical Sciences, Guangzhou 510080, China.
Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong, Academy of Medical Sciences, Guangzhou 510080, China; Centre of Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, UK.
出版信息
Lancet. 2023 Feb 25;401(10377):643-644. doi: 10.1016/S0140-6736(23)00213-1.
Abstract
摘要
相似文献
1
China's COVID-19 reopening measures-warriors and weapons.
Lancet. 2023 Feb 25;401(10377):643-644. doi: 10.1016/S0140-6736(23)00213-1.
2
Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
J Med Internet Res. 2021 Jun 17;23(6):e27345. doi: 10.2196/27345.
3
Measuring the Market Power of China's Medical Product Exports.
Front Public Health. 2022 Mar 31;10:875104. doi: 10.3389/fpubh.2022.875104. eCollection 2022.
4
Continuous focus on COVID-19 epidemic: Changes in China's clinical guidance.
Int J Clin Pract. 2021 Mar;75(3):e13869. doi: 10.1111/ijcp.13869. Epub 2020 Dec 16.
5
China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
Front Public Health. 2021 Dec 15;9:756677. doi: 10.3389/fpubh.2021.756677. eCollection 2021.
6
Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
Front Public Health. 2021 Apr 23;9:610824. doi: 10.3389/fpubh.2021.610824. eCollection 2021.
7
Evaluation of China's public health system response to COVID-19.
J Glob Health. 2021 Jan 16;11:05004. doi: 10.7189/jogh.11.05004.
8
Response to COVID-19 in the Central African Republic: Coping Strategies Combined With China's Experience.
Int J Public Health. 2022 Apr 25;67:1604344. doi: 10.3389/ijph.2022.1604344. eCollection 2022.
9
China's community-based crisis management model for COVID-19: A zero-tolerance approach.
Front Public Health. 2022 Jul 22;10:880479. doi: 10.3389/fpubh.2022.880479. eCollection 2022.
10
The Impact of China's Legal System on Public Health and Quality of Life during the COVID-19 Pandemic: An Empirical Study.
Int J Environ Res Public Health. 2022 Oct 20;19(20):13598. doi: 10.3390/ijerph192013598.
引用本文的文献
1
Clinical, thyroid metabolic, and inflammatory features in pediatric patients with post-acute COVID-19 neuropsychiatric symptoms.
BMC Infect Dis. 2025 Jul 30;25(1):963. doi: 10.1186/s12879-025-11333-3.
2
Wastewater surveillance as a predictive tool for COVID-19: A case study in Chengdu.
PLoS One. 2025 May 28;20(5):e0324521. doi: 10.1371/journal.pone.0324521. eCollection 2025.
3
Comparison of plasma sterilizer and conventional laminar flow room in allogeneic hematopoietic stem cell transplant recipients.
Cell Transplant. 2025 Jan-Dec;34:9636897251335722. doi: 10.1177/09636897251335722. Epub 2025 Apr 30.
4
Identifying and Validating Prognostic Hyper-Inflammatory and Hypo-Inflammatory COVID-19 Clinical Phenotypes Using Machine Learning Methods.
J Inflamm Res. 2025 Feb 27;18:3009-3024. doi: 10.2147/JIR.S504028. eCollection 2025.
5
Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12-2023.4 wave of the COVID-19 pandemic.
Front Immunol. 2024 Nov 6;15:1476186. doi: 10.3389/fimmu.2024.1476186. eCollection 2024.
6
Antibody response to SARS-CoV-2 natural and breakthrough infection in patients undergoing maintenance hemodialysis: A prospective cohort study over 4 months.
Heliyon. 2024 Sep 26;10(19):e38545. doi: 10.1016/j.heliyon.2024.e38545. eCollection 2024 Oct 15.
7
Associations between pre-infection serum vitamin D concentrations and Omicron COVID-19 incidence, severity and reoccurrence in elderly individuals.
Public Health Nutr. 2024 Oct 7;27(1):e197. doi: 10.1017/S1368980024001873.
8
Trends and factors influencing the mental health of college students in the post-pandemic: four consecutive cross-sectional surveys.
Front Psychol. 2024 Jul 17;15:1387983. doi: 10.3389/fpsyg.2024.1387983. eCollection 2024.
9
Acute primary angle closure concurrent with coronavirus disease 2019 recurrence in Northern China: A retrospective multi-centre study.
Heliyon. 2024 Jul 4;10(13):e34090. doi: 10.1016/j.heliyon.2024.e34090. eCollection 2024 Jul 15.
10
New findings on retinal microvascular changes in patients with primary COVID-19 infection: a longitudinal study.
Front Immunol. 2024 May 21;15:1404785. doi: 10.3389/fimmu.2024.1404785. eCollection 2024.
本文引用的文献
1
VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023 Feb 2;388(5):406-417. doi: 10.1056/NEJMoa2208822. Epub 2022 Dec 28.
2
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study.
Lancet. 2022 Oct 8;400(10359):1213-1222. doi: 10.1016/S0140-6736(22)01586-0.
3
The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta.
J Travel Med. 2022 May 31;29(3). doi: 10.1093/jtm/taac037.
Zotero 插件